Advertisement

Ceftriaxone Sodium Injection

[05 August 2015]

Products Affected - Description

Ceftriaxone injection, Apotex
250 mg, vial, 10 count (NDC 60505-0750-04)
500 mg, vial, 10 count (NDC 60505-0751-00)
 
Ceftriaxone injection, Sandoz
1 gram, vial, 10 count (NDC 00781-3208-95)
10 gram, vial, 1 count (NDC 00781-3210-46)
2 gram, vial, 10 count (NDC 00781-3209-95)
250 mg, vial, 10 count (NDC 00781-3206-95)
500 mg, vial, 10 count (NDC 00781-3207-95)
 
Ceftriaxone injection, WG Critical Care
1 gram, vial, 25 count (NDC 44567-0701-25)

Reason for the Shortage

  • Ben Venue stopped production in its plant in Bedford, Ohio and closed in July 2014.
  • Fresenius Kabi states the reason for the shortage is increased demand.
  • Hospira has a consistent supply of ceftriaxone injection. 
  • Sagent states the reason for the shortage is increased demand.
  • Sandoz cannot provide a reason for the shortage.
  • WG Critical Care states the reason for the shortage is increased demand.

Available Products

Ceftriaxone sodium injection, Apotex
1 gram, vial, 10 count (NDC 60505-0752-04)
2 gram vials, 10 count (NDC 60505-0753-04)
10 gram, vial, 1 count (NDC 60505-0679-05)
 
Ceftriaxone sodium injection, BBraun
1 gram/50 mL premix, 24 count (NDC 00264-3153-11)
2 gram/50 mL premix, 24 count (NDC 00264-3155-11)

Ceftriaxone sodium injection, Baxter
1 gram/50 mL premix, 24 count (NDC 00338-5002-41)
2 gram/50 mL premix, 24 count (NDC 00338-5003-41)

Ceftriaxone injection, Fresenius Kabi
1 gram, vial, 25 count (NDC 63323-0346-10)
2 gram, vial, 10 count (NDC 63323-0347-20)
10 gram, vial, 1 count, NDC 63323-0348-61)
250 mg, vial, 25 count (NDC 63323-0344-10)
500 mg, vial, 25 count (NDC 63323-0345-10)
 
Ceftriaxone sodium injection, Hospira
1 gram, ADD-Vantage vial, 10 count (NDC 00409-7333-04)
1 gram, vial, 10 count (NDC 00409-7332-01)
2 gram, ADD-Vantage vial, 10 count (NDC 00409-7336-04)
2 gram, vial, 10 count (NDC 00409-7335-03)
10 gram, vial, 1 count (NDC 00409-7334-10)
250 mg, vial, 10 count (NDC 00409-7337-01)
500 mg, vial, 10 count (NDC 00409-7338-01)
 
Ceftriaxone sodium injection, Lupin
1 gram, vial, 10 count (NDC 68180-0633-10)
2 gram, vial, 10 count (NDC 68180-0644-10)
250 mg, vial, 10 count (NDC 68180-0611-10)
500 mg, vial, 10 count (NDC 68180-0622-10)
 
Ceftriaxone sodium injection, Sagent
1 gram, vial, 25 count (NDC 25021-0106-10)
2 gram, vial, 25 count (NDC 25021-0107-20)
10 gram, vial, 1 count (NDC 25021-0108-99)
500 mg, vial, 25 count (NDC 25021-0105-10)
 
Ceftriaxone injection, Samson Medical Technologies
100 gram, SmartPak bulk vial, 1 count (NDC 66288-6100-01)
 
Ceftriaxone sodium injection, WG Critical Care
10 gram, vial, 1 count (NDC 44567-0703-01)
2 gram, vial, 25 count (NDC 44567-0702-25)
 
Ceftriaxone sodium injection, West-Ward
1 gram, vial, 25 count (NDC 00143-9857-25)
2 gram, vial, 25 count (NDC 00143-9856-25)
250 mg, vial, 25 count (NDC 00143-9859-25)
500 mg, vial, 25 count (NDC 00143-9858-25)

Estimated Resupply Dates

  • Apotex has ceftriaxone 500 mg vials on back order and the company estimates a release date in mid-October 2015. Ceftriaxone 250 mg vials are on back order and the company estimates a release date in late-August to early-September 2015.
  • Sandoz has all ceftriaxone presentations on back order and the company cannot estimate a release date.
  • WG Critical Care has ceftriaxone 1 gram vials on intermittent back order and the company is releasing product as it becomes available. Check wholesaler for availability.

Related Shortages

Updated

August 5, July 10 and 16, June 23, 22 and 5, May 8, April 8, 16, and 20; March 10, February 3, January 9, 2015; December 12, November 4, 7, 19, 21, and 26, October 9, September 4, 15, and 25, August 6 and 21, July 9, 14, and 21, June 17, 2014; June 3, May 1, 8, 14, and 29, 2014, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement